173 related articles for article (PubMed ID: 10331373)
1. Berkeley dispute festers over biotech deal.
Dalton R
Nature; 1999 May; 399(6731):5. PubMed ID: 10331373
[No Abstract] [Full Text] [Related]
2. Syngenta ends plant-research deal with Berkeley.
Dalton R
Nature; 2003 Nov; 426(6964):216. PubMed ID: 14628007
[No Abstract] [Full Text] [Related]
3. Biotech funding deal judged to be 'a mistake' for Berkeley.
Dalton R
Nature; 2004 Aug; 430(7000):598. PubMed ID: 15295560
[No Abstract] [Full Text] [Related]
4. Blurred vision.
Smaglik P
Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
[No Abstract] [Full Text] [Related]
5. Building cooperation New York.
Smaglik P
Nature; 2002 Sep; 419(6905):4-5. PubMed ID: 12352990
[No Abstract] [Full Text] [Related]
6. Good neighbours.
Niiler E
Nature; 2003 Dec; 426(6967):690-4. PubMed ID: 14668872
[No Abstract] [Full Text] [Related]
7. No mistake in Berkeley's biotechnology deal.
Hultin PG
Nature; 2004 Oct; 431(7009):627. PubMed ID: 15470401
[No Abstract] [Full Text] [Related]
8. Florida lures research institutes east.
Dalton R
Nature; 2006 Aug; 442(7104):729. PubMed ID: 16915254
[No Abstract] [Full Text] [Related]
9. Developing an intellectual property portfolio for the academic or not-for-profit institution.
Bloomberg CA
Nat Biotechnol; 2005 Jan; 23(1):119-21. PubMed ID: 15637626
[No Abstract] [Full Text] [Related]
10. Biotech parks proliferate, despite concerns over sustainability.
Jia H; Jayaraman KS; Orellana C
Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
[No Abstract] [Full Text] [Related]
11. Universities could gain from backing biotech.
Kamb A
Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634753
[No Abstract] [Full Text] [Related]
12. Genesis of a high-tech hub.
Veltman C
Nature; 2003 Dec; 426(6967):700-4. PubMed ID: 14668874
[No Abstract] [Full Text] [Related]
13. Syngenta ready to drop plans for Indian rice venture.
Jayaraman KS
Nature; 2002 Dec; 420(6916):596. PubMed ID: 12478254
[No Abstract] [Full Text] [Related]
14. Berkeley teams up with Novartis in $50m plant genomics deal.
Macilwain C
Nature; 1998 Nov; 396(6706):5. PubMed ID: 9817194
[No Abstract] [Full Text] [Related]
15. Marketing biotechnology with a Gallic flair.
Jouanneau AC
Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
[No Abstract] [Full Text] [Related]
16. Berkeley accused of biotech bias as ecologist is denied tenure.
Dalton R
Nature; 2003 Dec; 426(6967):591-5914. PubMed ID: 14668822
[No Abstract] [Full Text] [Related]
17. University challenge Paris.
Goodman S
Nature; 2003 Apr; 422(6932):644-5. PubMed ID: 12687008
[No Abstract] [Full Text] [Related]
18. Winds of change blow away the cobwebs on campus.
Cyranoski D; Chou IH
Nature; 2004 May; 429(6988):210-4. PubMed ID: 15141219
[No Abstract] [Full Text] [Related]
19. Danish biotech centre faces axe.
Abbott A
Nature; 2003 Mar; 422(6928):105. PubMed ID: 12634749
[No Abstract] [Full Text] [Related]
20. Faculty start-ups offer temptation to breach academic rules . . . but Syngenta deal is a boon to Berkeley.
Metz M
Nature; 2001 Mar; 410(6828):513. PubMed ID: 11279462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
